ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This phase I trial studies the effects of ONC201 in combination with standard of care radiation therapy in treating patients with glioblastoma that has come back (recurrent). ONC201 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Radiation therapy uses high energy photons to kill tumors cells and shrink tumors. Giving ONC201 in combination with radiation therapy may help treat patients with recurrent glioblastoma.
Epistemonikos ID: 01f7c262c60686268a23bd8865b7a0a0de9a4dfa
First added on: May 08, 2024